Form 4 Filing for Immunovant, Inc. - Insider Transactions

This Form 4 filing details insider transactions for Immunovant, Inc. (IMVT) on July 24, 2026. Reporting owner Atul Pande, a director, executed several transactions under a Rule 10b5-1 plan. Pande acquired 1,500 shares of Common Stock at $8.43 per share and disposed of 1,500 shares at $39.80 per share. Additionally, Pande exercised a stock option to acquire 1,500 shares of Common Stock, with the option having an exercise price of $8.43. Following these transactions, Pande directly holds 116,731 shares. The filing also notes indirect ownership of 20,000 shares held by a trust. A vested stock option award, exercisable until November 19, 2029, was also part of the reporting. The transactions were reported on a Form 4, indicating changes in beneficial ownership.